A Randomized Trial of Two Surgical Techniques for Pancreaticojejunostomy in Patients Undergoing Pancreaticoduodenectomy
Pancreatic Neoplasms, Biliary Tract Neoplasms, Pancreatitis, Chronic
About this trial
This is an interventional treatment trial for Pancreatic Neoplasms focused on measuring Pancreaticoduodenectomy, Pancreaticojejunostomy, Pancreatic Cancer
Eligibility Criteria
Inclusion Criteria: Patients must have undergone pancreaticoduodenectomy. Must have pancreatic remnant remaining in place (body and tail). Must be candidate for reconstruction by pancreaticojejunostomy by one of the two techniques described below. Must have an identifiable pancreatic duct which can be used for a duct-to-mucosa anastomosis. Exclusion Criteria: Patients undergoing total pancreatectomy. Patients undergoing PD who have had previous left-sided pancreatic resection. Failure to sign informed consent. Failure to identify the pancreatic duct. Pregnant patients.
Sites / Locations
- Thomas Jefferson University Hospital
Arms of the Study
Arm 1
Experimental
Mucosa-to-jejunal mucosa technique of pancreaticojejunosto
Determine whether a duct mucosa-to-jejunal mucosa technique of pancreaticojejunostomy will improve the pancreatic fistula rate